Page last updated: 2024-08-26

22-hydroxycholesterol and Gall Bladder Diseases

22-hydroxycholesterol has been researched along with Gall Bladder Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ji, ZL; Tan, YY; Wang, D; Wang, JM; Zhao, G	1

Other Studies

1 other study(ies) available for 22-hydroxycholesterol and Gall Bladder Diseases

Article	Year
22(R)-hydroxycholesterol and pioglitazone synergistically decrease cholesterol ester via the PPARγ-LXRα-ABCA1 pathway in cholesterosis of the gallbladder. Biochemical and biophysical research communications, 2014, Apr-25, Volume: 447, Issue:1 Topics: ATP Binding Cassette Transporter 1; Cells, Cultured; Cholesterol Esters; Drug Synergism; Epithelial Cells; Gallbladder; Gallbladder Diseases; Humans; Hydroxycholesterols; Hypercholesterolemia; Liver X Receptors; Orphan Nuclear Receptors; Pioglitazone; PPAR gamma; Thiazolidinediones	2014

Article

Year

22(R)-hydroxycholesterol and pioglitazone synergistically decrease cholesterol ester via the PPARγ-LXRα-ABCA1 pathway in cholesterosis of the gallbladder.

Biochemical and biophysical research communications, 2014, Apr-25, Volume: 447, Issue:1

Topics: ATP Binding Cassette Transporter 1; Cells, Cultured; Cholesterol Esters; Drug Synergism; Epithelial Cells; Gallbladder; Gallbladder Diseases; Humans; Hydroxycholesterols; Hypercholesterolemia; Liver X Receptors; Orphan Nuclear Receptors; Pioglitazone; PPAR gamma; Thiazolidinediones

2014